For copyright status please check original publication.
Citation
Health, C., 2023. CADTH Reimbursement Recommendation - Nelarabine (Atriance) - Indication: Nelarabine (Atriance) for addition to front-line multiagent therapy, Canadian Agency for Drugs and Technologies in Health.
Canada
Retrieved from https://coilink.org/20.500.12592/7kvdbc on 07 Sep 2024. COI: 20.500.12592/7kvdbc.
If your institution is a member, please log into
Canada Commons from a link provided by your institution. This typically
involves logging in via a menu managed by your library.
If your institution is a member, please log into Policy
Commons from a link provided by your institution. This typically involves
logging in via a menu managed by your library.